在COVID-19疫苗接种期间,首次报告了带有系统性参与的红皮皮质沙尔科毒症病例
Georgi Tchernev1,2, Simona Kordeva1, Heily Kirilova2
1Onkoderma - Clinic for Dermatology, Venereology and Dermatologic Surgery, Sofia.
Dermatology reports
|July 10, 2023
概括
这项研究报告了一种罕见的皮质红皮类瘤病例,在ChadOx1-S COVID-19疫苗接种后系统性参与. 早期使用甲基prednisolone和Pimecrolimus奶油的治疗导致症状迅速改善,这表明疫苗潜在的副作用.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 疫苗接种后的免疫激活可以触发免疫性疾病,可能是通过分子模仿.
- 肉病和肉类反应的发病原因仍然不太清楚.
- 这些反应可能表明潜在的组织稳态障碍.
研究的目的:
- 报告一种罕见的皮质红色皮质肉类症病例,涉及广泛的全身疾病.
- 为了调查这种情况与ChadOx1-S COVID-19疫苗之间的潜在关联.
- 突出疫苗接种的新型潜在不良影响.
主要方法:
- 一个病人的病例报告,在接种疫苗后发生了红皮皮质类病.
- 系统性参与的详细文档,包括心膜炎,肝炎和肺纤维化.
- 治疗开始时使用全身免疫抑制剂 (甲基prednisolone) 和局部Pimecrolimus.
主要成果:
- 这位患者呈现出一种罕见的红皮皮质类瘤症,具有显著的全身表现.
- 在开始免疫抑制治疗后两天内观察到快速的临床改善.
- 这代表了首次描述的与疫苗相关的红皮皮质沙尔科毒症病例,其系统性参与.
结论:
- 带有系统性参与的皮质红皮样症可能是ChadOx1-S COVID-19疫苗接种后的罕见不良影响.
- 早期的免疫抑制治疗可以有效地控制症状.
- 这一案例凸显了疫苗接种后对罕见免疫反应的监测的重要性.
相关概念视频
Vaccinations
44.8K
Overview
44.8K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Myocarditis I: Introduction
10
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Myocarditis II: Clinical Features and Diagnostic Tests
12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Pericarditis I: Introduction
12
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
12
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9


